After announcing their approval of the first vaccine against SARS-CoV-2 earlier this week, the UK government has now released the 'REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS' document for COVID-19 mRNA Vaccine BNT162b2. Similar to a standard summary of product characteristics, this document contains additional details about the trial design, patient demographics,...